AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. AxoGen (AXGN) might move higher on growing optimism ...

David Turkaly, an analyst from JMP Securities, reiterated the Buy rating on AxoGen (AXGN – Research Report). The associated price target remains the same with $20.00. David Turkaly has given his ...

Have you been paying attention to shares of AxoGen (AXGN)? Shares have been on the move with the stock up 27.6% over the past month. The stock hit a new 52-week high of $17.23 in the previous session.

AxoGen ( (AXGN)) has released its Q3 earnings. Here is a breakdown of the information AxoGen presented to its investors. Axogen, Inc. is a leading company dedicated to the development and ...